Comparison of Resistance to the Antibiotics Penicillin, Erythromycin, Oxacillin, Chloramphenicol and Vancomycin in Staphylococcus aureus Isolated from Healthy Adults in the United States of America and Mexico
Mrs. Dorothy
Don Davis
Department of Biological and Physical Sciences
Kennesaw State University, 1000 Chastain Rd.
Kennesaw, GA 30144, USA
ABSTRACT
Our investigation
indicates there are significant differences in the throat
carriage of Staphylococcus aureus resistant to antibiotics
(penicillin G, oxacillin, erythromycin, chloramphenicol
and vancomycin) in a population in Mexico compared to
a similar population in the United States of America
(USA). Throat isolates were obtained from 105 healthy
adults from the USA (Kennesaw State University, Kennesaw,
Georgia, USA) and from 76 healthy adults from Mexico
(Xalapa, Veracruz, Mexico.) The data indicate a significantly
greater number of resistant isolates of Staphylococcus
aureus from the Mexican population (16) than from the
USA population (7). Factors that may contribute to these
differences were identified from questionnaires completed
by each participant. These factors were: 1) a greater
percentage of individuals in the Mexico population seek
the care of a physician for allergies; 2) a greater
percentage of individuals in Mexico have used antibiotics
recently; 3) all of the antibiotics used in this investigation
are available in Mexico without a prescription from
a physician, but none are available in the USA without
a prescription from a physician.
WORD KEY: Antibiotic resistance, Staphylococcus aureus,
penicillin, oxacillin, erythromycin, chloramphenicol,
vancomycin
RESUMEN
Nuestra
investigación indica que existen diferencias
significativas en la portación en garganta de
Staphylococcus aureus resistente a antibióticos
(penicilina G, oxacilina, eritromicina, cloranfenicol
y vancomicina) en una población en México
comparada con una población similar en los Estados
Unidos de Norteamérica (USA). Los aislamientos
de garganta se obtuvieron de 105 adultos saludables
de los Estados Unidos (Kennesaw State University, Kennesaw,
Georgia, USA) y de 76 adultos saludables de México
(Xalapa, Veracruz, México). Los datos arrojan
un número significativamente mayor de aislamientos
resistentes de Staphylococcus aureus en la población
mexicana (16) que en el de la población de EU
(7). Los factores que pueden contribuir a estas diferencias
fueron identificados a partir de cuestionarios completados
por cada participante. Estos factores fueron: 1) un
porcentaje mayor de individuos en la población
de México acuden al médico por alergias;
2) un porcentaje mayor de individuos en México
ha usado antibióticos recientemente; 3) todos
los antibióticos usados en esta investigación
se encuentran disponibles en México sin prescripción
médica, pero ninguno se encuentra disponible
en EU sin la misma.
PALABRAS CLAVE: Resistencia antibiótica, Staphylococcus
aureus, penicilina, oxacilina, eritromicina, cloranfenicol,
vancomicina
INTRODUCTION
There is a rapid increase world-wide in the numbers
of bacteria resistant to antibiotics. Most resistance
arises due to the over use or misuse of antibiotics
for: medicinal purposes (1), agricultural purposes (2),
and purposes of disinfection (3), thus selecting for
resistant organisms. Each day it becomes more difficult
to find antibiotics that effectively treat common but
serious infections (4, 5, 6). The majority of information
about antibiotic resistance in the scientific literature
pertains to bacterial isolates from infections that
did not respond to treatment with antibiotics. There
is little data in the scientific literature about resistance
to antibiotics in bacteria isolated from healthy individuals
(5). In particular, we are not able to find any data
about resistance in Staphylococcus aureus isolated from
healthy adults.
This study attempts to determine the prevalence of carriage
of antibiotic resistant Staphylococcus aureus by healthy
persons. This investigation compared data obtained from
healthy adults in two areas, Mexico and the United States
of America (USA) for the 1) presence of antibiotic resistant
Staphylococcus aureus, 2) factors from health histories
from each individual, and 3) the availability of antibiotics.
This investigation concentrates on Staphylococcus aureus
because it is one of the most important causes of serious
infection in hospitalized patients as well as in persons
with immune system impairment. It is easy to identify
and grow, and it is the bacterium that was most commonly
isolated by our investigation in both countries. Also
there is much information in the scientific literature
about Staphylococcus aureus.
It is important to have a better understanding of factors that may predispose healthy persons to carriage of antibiotic resistant organisms. This knowledge may help us identify health or environmental factors that could be manipulated to reduce the carriage of antibiotic resistant organisms. Perhaps this knowledge could also reduce the prevalence of these resistant organisms and thus the infections they may cause.
METHODS
Data were obtained from healthy adults (>
18 years of age) from two populations: 105 adults from
the area of Kennesaw State University (Kennesaw, Georgia,
USA) and 76 adults from the area of the Hospital Escuela
de Ginecologia y Obstetricia (Xalapa, Veracruz, Mexico)
during the summer of 2001 by the students of a research
class from Kennesaw State University.
Isolates were obtained from the fauces of adults by
means of a sterile swab, and the organisms were isolation
streaked onto 5% sheep blood agar. Isolated colonies
were further cultured and identified by hemolytic reaction,
gram reaction, catalase production, and reaction on
Mannitol Salt Agar.
Finally, they were analyzed using the disk method on
Mueller Hinton Agar for resistance to five antibiotics:
penicillin G, oxacillin, erythromycin, chloramphenicol,
and vancomycin. The methods and materials were the same
in both countries, following the guidelines of “The
National Committee for Clinical
Laboratory Standards for Antimicrobial Disk Susceptibility”
(7). The results were recorded and analyzed using Chi-Square
analysis, with p = 0.05.
Each individual tested was asked to complete a questionnaire.
This data was used to compare population characteristics
and to identify the possible factors that might influence
the numbers of antibiotic resistant strains isolated
from each population. The factors investigated included:
demographic data, information about smoking, medical
history, and the availability of antibiotics in both
countries.
RESULTS
There were significantly more isolates of Staphylococcus
aureus from the Mexican population (16 isolates from
76 persons) than from the USA population (7 isolates
from 105 persons). The data indicate more isolates of
antibiotic resistant Staphylococcus aureus in the Mexican
population than in the USA population. Of the 16 isolates
of Staphylococcus aureus in Mexico, 11 showed multiple
resistance to penicillin, erythromycin, and oxacillin;
8 showed resistance to chloramphenicol, and 4 showed
intermediate resistance to vancomycin. Of the 7 Staphylococcus
aureus isolated from the USA population, 2 showed resistance
to penicillin, 2 to erythromycin, 5 were resistant to
oxacillin and 5 to chloramphenicol, and 7 showed intermediate
resistance to vancomycin. (Table 1) Obviously, from
this data, many isolates were multiply resistant. This
data has been combined for brevity because each isolate
had its own resistance pattern.
Table
1
Comparison of Resistance and Intermediate
Resistance in Staphylococcus aureus
Number
of Staphylococcus aureus Isolates |
||||||
Country | Total | P | E | O | C | V |
Mexico | 16 | 11 | 11 | 11 | 8 | 4 |
USA | 7 | 2 | 2 | 5 | 5 | 7 |
P = penicillin,
intermediately resistant or resistant
E = erythromycin, intermediately resistant or resistant
O = oxacillin, intermediately resistant or resistant
C = cloramphenicol, intermediately resistant or resistant
V = vancomycin, intermediately resistant or resistant
There is
a significant difference between Mexico and the USA
in each category
Evaluated by Chi-Square p < 0.05
Using the data from the questionnaires to compare the characteristics of the two populations, there were no significant differences in the average age (in Mexico 36 years, and in the USA 34 years) or in the distribution by sex (in Mexico 24 men, 52 women; in the USA 39 men, 65 women). (Table 2)
Table 2
Comparison of Characteristics of the Populations
Country |
Sex |
Average
age |
|
Male |
Female |
Years |
|
Mexico |
24 |
52 |
36 |
USA |
39 |
65 |
34 |
There are no significant differences
Data from
the questionnaires show that there are significant differences
between the two populations that might influence whether
or not a person carried antibiotic resistant Staphylococcus.
More persons in Mexico (43% -- 32 of 76 persons) have
allergies severe enough to consult a physician compared
with the USA population (16% -- 17 of 105 persons).
(Table 3)
Unpublished data indicate that a person who consults
a physician for allergy problems is more likely to carry
antibiotic resistant Staphylococcus than a person who
does not consult a physician because of allergies. (Perhaps
this increase of carriage of resistant Staphylococcus
by allergic persons is due to increased likelihood of
respiratory tract infections and resulting greater antibiotic
use.) (8) The data indicate that more persons in the
Mexico population (19 of 76 persons) have recently used
antibiotics compared to the USA population (21 of 105
persons). (Table 3)
Table 3
Comparison of allergy prevalence and recently taking
antibiotics
Country |
Consult
a doctor for allergies |
Have
taken antibiotics recently* |
Mexico |
43% |
25% |
USA |
16% |
20% |
There is a significant
difference between Mexico and the USA in both categories
Evaluated by Chi-Square p < 0.05
Actual numbers used, not percentages, in Chi-Square
evaluation
*within the past 6 months
Another factor of importance is that all the antibiotics used in this investigation are available without a prescription from a physician in Mexico. None of these antibiotics are available without a prescription from a physician in the USA.
CONCLUSIONS
This investigation has found a significantly greater number of antibiotic resistant isolates of Staphylococcus aureus in the Mexican population tested than in the USA population tested. The numbers of persons sampled in each population were relatively small (76 in Mexico, 105 in USA), but the comparisons were so strikingly different that the significant differences seem reliable. We were not able to determine all the factors that may contribute to the differences in numbers of resistant isolates. However, there are significant differences in the data from the questionnaires that show greater numbers of persons with serious allergies, greater use of antibiotics, and less restrictive availability of antibiotics without a prescription in Mexico. These may be important factors contributing to the selection of antibiotic resistant bacteria. Further investigations are needed to increase the database and sample size so that we can understand more completely the serious problem of antibiotic resistance and thus promote the health of persons in both countries. (9)
ACKNOWLEDGEMENTS
•
Dr. Carlos Blázquez Domínguez, Director,
Hospital Escuela de Ginecología y Obstetricia,
Universidad Veracruzana, Xalapa, México (technical
help)
• Q.C. J.J. Daniel López Muñoz ,
Jefe del Laboratorio, Hospital Escuela de Ginecología
y Obstetricia, Universidad Veracruzana, Xalapa, México
(technical help)
• Dra. Sobeida Blázquez Morales, Cirujana.
Jefa de Enseñanza , Hospital Escuela de Ginecología
y Obstetricia, Universidad Veracruzana, Xalapa, México
(technical help)
• Mtra. Virginia Mateu
Armand, (Coordinadora de Servicios), Escuela para Estudiantes
Extranjeros de la Universidad Veracruzana, Xalapa, México
(translation)
• Amy Walthour, Adam O’Bryant, Michelle
Swann, Sandra Medina: estudiantes de Kennesaw State
University, Georgia, EUA. (collection of data)
• Dr. Lewis Van Brackle, Departamento de Matemáticas
Kennesaw State University, Georgia, EUA (technical help
– statistics)
• Dra. Paola Jackson, Departamento de Biología,
Kennesaw State University, Georgia, EUA. ( translation)
• Sr. Dale Zaborowski, Director de los Laboratorios
Biológicos, Kennesaw State University, Georgia,
EUA. (technical help)
• Americas Council of the Board of Regents, University
of Georgia System (financial support)
• Kennesaw State University, Oficina de la Presidente
(financial support)
• Kennesaw State University, Oficina de los Estudios
en el Extranjero (financial support)
REFERENCES
1. Abramson
JS, Givner LB. Bacterial Resistance Due to Antimicrobial
Drug Addiction among Physicians. Jan-Feb. Archives of
Family Medicine. 1999; 8:79-80.
2. Avorn JA, Solomon DH. Cultural and Economic Factors
that (Mis)Shape Antibiotic Use:The Nonpharmacologic
Basis of Therapeutics.Annals of Internal Medicine. July
18, 2000; 133: 2:128-135. (Available on line) wysiwyg://61/http://www.annals.org/issues/v133n2/full/200007180-00012.html
(Accessed Sept. 25, 2000).
3. CDC. Septic arthritis following anterior cruciate
ligament reconstruction using tendon allografts---Florida
and Louisiana 2000. MMWR. 2001; 50:1081—3.
4. Arya S. Antibiotic Resistance in the Two Americas.
ASM News. September, 1999; 65:9:585.
5. Calva JJ, Sifuentes-Osornio J, Cerón C. Antimicrobial
Resistance in Fecal Flora:Longitudinal Community-Based
Surveillance of Children from Urban México, Antimicrobial
Agents and Chemotherapy. July 1996; 40:7:1699 –
1702.
6. Fauci AS, Antimicrobial Resistance: The NIH Response
to a Growing Problem. Statement before the Senate Committee
on Health Education.Labor and Pensions, Subcommittee
on Public Health and Safety. Feb 25, 1999. (Available
on line) http://www.niaid.nih.gov/director/congress/1999/0225.htm
(Accessed Sept. 25, 2000).
7. National Committee for Clinical Laboratory Standards.
Performance Standards for Antimicrobial Disk Susceptibility
Tests:Approved Standard-Seventh Edition. January, 2000;
M2-A7. 10:l.
8. Kluytmans J. VanBelkum A. Verbrugh H. Nasal Carriage
of Staphylococcus aureus: Epidemiology, Underlying Mechanisms,
and Associated Risks, Clinical Microbiology Reviews.
July 1997; 10:3: 505-520.
9. Levy S, Cruz J. Two Americas Confront Antibiotic
Resistance. ASM News. March 1999; 65:3. Available online.
http://www.asm.org/pcsrc/news/3099b.htm (Accessed Oct.
16, 2000).